My NCBI | Sign In
RSS Settings
  • Search: Romagné F[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 46

    1.

    NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients.

    Johansson SE, Hejdeman B, Hinkula J, Johansson MH, Romagné F, Wahren B, Wagtmann NR, Kärre K, Berg L.

    Clin Immunol. 2009 Oct 30. [Epub ahead of print]PMID: 19880352 [PubMed - as supplied by publisher]Related articles

    2.

    Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

    Sola C, André P, Lemmers C, Fuseri N, Bonnafous C, Bléry M, Wagtmann NR, Romagné F, Vivier E, Ugolini S.

    Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84. Epub 2009 Jun 26.PMID: 19561305 [PubMed - indexed for MEDLINE]Related articles

    3.

    Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

    Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM Jr, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N.

    Blood. 2009 Sep 24;114(13):2667-77. Epub 2009 Jun 24.PMID: 19553639 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues.

    Benkoël L, Bernard JP, Payan-Defais MJ, Crescence L, Franceschi C, Delmas M, Ouaissi M, Sastre B, Sahel J, Benoliel AM, Bongrand P, Silvy F, Gauthier L, Romagné F, Lombardo D, Mas E.

    Mol Cancer Ther. 2009 Feb;8(2):282-91. Epub 2009 Feb 3.PMID: 19190122 [PubMed - indexed for MEDLINE]Related articles

    5.

    Phylotyping and functional analysis of two ancient human microbiomes.

    Tito RY, Macmil S, Wiley G, Najar F, Cleeland L, Qu C, Wang P, Romagne F, Leonard S, Ruiz AJ, Reinhard K, Roe BA, Lewis CM Jr.

    PLoS One. 2008;3(11):e3703. Epub 2008 Nov 11.PMID: 19002248 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.

    Viey E, Lucas C, Romagne F, Escudier B, Chouaib S, Caignard A.

    J Immunother. 2008 Apr;31(3):313-23.PMID: 18317356 [PubMed - indexed for MEDLINE]Related articles

    7.

    In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.

    Burjanadzé M, Condomines M, Reme T, Quittet P, Latry P, Lugagne C, Romagne F, Morel Y, Rossi JF, Klein B, Lu ZY.

    Br J Haematol. 2007 Oct;139(2):206-16.PMID: 17897296 [PubMed - indexed for MEDLINE]Related articles

    8.

    Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.

    Salot S, Laplace C, Saïagh S, Bercegeay S, Tenaud I, Cassidanius A, Romagne F, Dreno B, Tiollier J.

    J Immunol Methods. 2007 Sep 30;326(1-2):63-75. Epub 2007 Aug 7.PMID: 17716681 [PubMed - indexed for MEDLINE]Related articles

    9.

    Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.

    Vivier E, Romagné F.

    Immunity. 2007 May;26(5):549-51.PMID: 17521583 [PubMed - indexed for MEDLINE]Related articles

    10.

    Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

    Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E.

    Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9. Epub 2007 Feb 20.PMID: 17360655 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct gammadelta and alphabeta T cell responses in primates.

    Cendron D, Ingoure S, Martino A, Casetti R, Horand F, Romagné F, Sicard H, Fournié JJ, Poccia F.

    Eur J Immunol. 2007 Feb;37(2):549-65.PMID: 17230439 [PubMed - indexed for MEDLINE]Related articles

    12.

    Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.

    Romagne F.

    Drug Discov Today. 2007 Jan;12(1-2):80-7. Epub 2006 Nov 28. Review.PMID: 17198976 [PubMed - indexed for MEDLINE]Related articles

    13.

    Human NK cell education by inhibitory receptors for MHC class I.

    Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E.

    Immunity. 2006 Aug;25(2):331-42. Epub 2006 Aug 10.PMID: 16901727 [PubMed - indexed for MEDLINE]Related articles

    14.

    In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.

    Sicard H, Ingoure S, Luciani B, Serraz C, Fournié JJ, Bonneville M, Tiollier J, Romagné F.

    J Immunol. 2005 Oct 15;175(8):5471-80.PMID: 16210655 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.

    Stewart CA, Laugier-Anfossi F, Vély F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagné F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E.

    Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13224-9. Epub 2005 Sep 2.PMID: 16141329 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

    André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P.

    Eur J Immunol. 2004 Apr;34(4):961-71.PMID: 15048706 [PubMed - indexed for MEDLINE]Related articles

    17.

    Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.

    Scott-Algara D, Buseyne F, Blanche S, Rouzioux C, Jouanne C, Romagné F, Rivière Y.

    J Infect Dis. 2001 Jun 1;183(11):1565-73. Epub 2001 Apr 27.PMID: 11343205 [PubMed - indexed for MEDLINE]Related articles

    18.

    Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.

    Espinosa E, Belmant C, Pont F, Luciani B, Poupot R, Romagné F, Brailly H, Bonneville M, Fournié JJ.

    J Biol Chem. 2001 May 25;276(21):18337-44. Epub 2001 Feb 8.PMID: 11279081 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients.

    Palermo B, Campanelli R, Mantovani S, Lantelme E, Manganoni AM, Carella G, Da Prada G, della Cuna GR, Romagne F, Gauthier L, Necker A, Giachino C.

    Eur J Immunol. 2001 Feb;31(2):412-20.PMID: 11180105 [PubMed - indexed for MEDLINE]Related articles

    20.

    Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements.

    Vely F, Peyrat M, Couedel C, Morcet J, Halary F, Davodeau F, Romagne F, Scotet E, Saulquin X, Houssaint E, Schleinitz N, Moretta A, Vivier E, Bonneville M.

    J Immunol. 2001 Feb 15;166(4):2487-94.PMID: 11160309 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    9 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity